Management of osteoarthritis with Hyaluronic acid
Consensus statement on viscosupplementation with hyaluronic acid for the management of osteoarthritis
Article specifications
This article was published in 2015 in Journal of Seminars in Arthritis and Rheumatism (IF 2015:2.71) by Eight European experts from Belgium, France, Germany, Italy, and UK. The purpose of this study was to evaluate the effect of viscosupplement with Hyaluronic acid for management of osteoarthritis. Overall, 24 statements on HA and VS were discussed during the meeting.
Results
VS is an effective treatment for mild to moderate knee OA; VS is not an alternative to surgery in advanced hip OA; VS is a well-tolerated treatment of knee and other joints OA; VS should not be used only in patients who have failed to respond adequately to analgesics and NSAIDs; VS is a “positive” indication but not a “lack of anything better” indication; the dosing regimen must be supported by evidence-based medicine
Tags: Italy Belgium Britain Germany France Seminars in Arthritis and Rheumatism 2015